Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Combivent HFA vs CFC in COPD
NCT02182869Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2001
- Primary completion
- Aug 2001
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 2 trial of Combivent in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Apr 2001; status: terminated.
02
Drugs
Combivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02182869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182869.